10x Genomics (TXG) Stock Price, Quote, News & History

Comments

10x Genomics Inc (TXG) Stock Price, Quote, News & History

TXGNASDAQ

Trade with Public

$16.69

-2.10-11.18%

At close: Mar 13, 5:00 PM EST

$16.73

-2.06-10.96%

Pre-Market: 7:09 AM EST

OverviewNews Earnings Options Guidance Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

-

Close

$16.69

Volume / Avg.

317.00 / 2.53M

Day Range

- - -

52 Wk Range

6.78 - 23.56

Market Cap

$2.14B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

26

Short Interest

20.28%

Days to Cover

6.41

Recent 10X Genomics Inc News

Breaking Down 10x Genomics: 11 Analysts Share Their Views

Benzinga Insights

PRO
Stifel Maintains Buy on 10x Genomics, Raises Price Target to $25

Stifel analyst Daniel Arias maintains 10x Genomics (NASDAQ:TXG) with a Buy and raises the price target from $20 to $25.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on 10x Genomics, Raises Price Target to $20

UBS analyst Dan Leonard maintains 10x Genomics (NASDAQ:TXG) with a Neutral and raises the price target from $14 to $20.

Benzinga Newsdesk

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

136.05M

Investing Cash Flow (TTM)

-13.44M

Financing Cash Flow (TTM)

6.80M

Free Cash Flow (TTM)

130.12M

Capital Expenditure (TTM)

-5.94M

Net Change in Cash (TTM)

129.42M

Analyst Trends and Forecast

2

3

Nov 25

2

Dec 25

3

Jan

1

Feb

1

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.9

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.69B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

3.24

PB Ratio (TTM)

2.68

Earnings Yield % (TTM)

-2.10%

Earnings Yield % (FWD)

-3.76%

EV / EBITDA (TTM)

433.14

Price / EBITDA (TTM)

532.64

Price / Free Cash Flow (TTM)

16.00

Book Value / Share

$6.23

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$473.97M

Debt to Equity

0.11

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

-

Close

$16.69

Volume / Avg.

317.00 / 2.53M

Day Range

- - -

52 Wk Range

6.78 - 23.56

Market Cap

$2.14B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

26

Short Interest

20.28%

Days to Cover

6.41

About

Sector

Health Care

Industry

Life Sciences Tools & Services

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and ...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy 10x Genomics (TXG) stock?

A

You can purchase shares of 10x Genomics (NASDAQ:TXG) through any online brokerage.

View our list of the best stock brokerages

Q

Who are 10x Genomics (TXG) competitors?

A

Other companies in 10x Genomics’s space includes: Medpace Holdings Inc (NASDAQ:MEDP), Agilent Technologies Inc (NYSE:A), Icon PLC (NASDAQ:ICLR), BioLife Solutions Inc (NASDAQ:BLFS) and Waters Corp (NYSE:WAT).

Q

What is the forecast, or price target, for 10x Genomics (TXG) stock?

A

10x Genomics has a consensus price target of $18.09.

Q

What is the current price for 10x Genomics (TXG)?

A

The stock price for 10x Genomics (NASDAQ: TXG) is $16.73 last updated March 16, 2026 at 7:46 PM EDT.

Q

Does 10x Genomics (TXG) pay a dividend?

A

There are no upcoming dividends for 10x Genomics.

Q

When is 10x Genomics (NASDAQ:TXG) reporting earnings?

A

10x Genomics does not have any upcoming earnings scheduled.

Q

Is 10x Genomics (TXG) going to split?

A

There is no upcoming split for 10x Genomics.

Q

What sector and industry does 10x Genomics (TXG) operate in?

A

10x Genomics is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

People Also Watch

Agilent Technologies Inc

BioLife Solutions Inc

AbCellera Biologics Inc

NASDAQ:ABCL

$3.55

-0.28%

Key Statistics

Open

-

Close

$16.69

Volume / Avg.

317.00 / 2.53M

Day Range

- - -

52 Wk Range

6.78 - 23.56

Market Cap

$2.14B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

26

Short Interest

20.28%

Days to Cover

6.41

Recent 10X Genomics Inc News

Breaking Down 10x Genomics: 11 Analysts Share Their Views

Benzinga Insights

PRO
Stifel Maintains Buy on 10x Genomics, Raises Price Target to $25

Stifel analyst Daniel Arias maintains 10x Genomics (NASDAQ:TXG) with a Buy and raises the price target from $20 to $25.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on 10x Genomics, Raises Price Target to $20

UBS analyst Dan Leonard maintains 10x Genomics (NASDAQ:TXG) with a Neutral and raises the price target from $14 to $20.

Benzinga Newsdesk

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

136.05M

Investing Cash Flow (TTM)

-13.44M

Financing Cash Flow (TTM)

6.80M

Free Cash Flow (TTM)

130.12M

Capital Expenditure (TTM)

-5.94M

Net Change in Cash (TTM)

129.42M

Analyst Trends and Forecast

2

3

Nov 25

2

Dec 25

3

Jan

1

Feb

1

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.9

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.69B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

3.24

PB Ratio (TTM)

2.68

Earnings Yield % (TTM)

-2.10%

Earnings Yield % (FWD)

-3.76%

EV / EBITDA (TTM)

433.14

Price / EBITDA (TTM)

532.64

Price / Free Cash Flow (TTM)

16.00

Book Value / Share

$6.23

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$473.97M

Debt to Equity

0.11

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

-

Close

$16.69

Volume / Avg.

317.00 / 2.53M

Day Range

- - -

52 Wk Range

6.78 - 23.56

Market Cap

$2.14B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

26

Short Interest

20.28%

Days to Cover

6.41

About

Sector

Health Care

Industry

Life Sciences Tools & Services

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and ...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry